Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fatemeh Elham Kani"'
Autor:
Yekta Parsa, Seyed Abbas Mirmalek, Fatemeh Elham Kani, Amir Aidun, Seyed Alireza Salimi-Tabatabaee, Soheila Yadollah-Damavandi, Ehsan Jangholi, Tina Parsa, Ehsan Shahverdi
Publikováno v:
Electronic Physician, Vol 8, Iss 5, Pp 2416-2424 (2016)
Background: Histologically similar tumors may have different prognoses and responses to treatment. These differences are due to molecular differences. Hence, in this review, the biological interaction of breast cancer in several different areas is
Externí odkaz:
https://doaj.org/article/3040f31a2b9648db896b58d256eb82b9
Autor:
Seyed Abbas Mirmalek, Fatemeh Elham Kani, Arianeb Mehrabi, Mehdi Chavoshi-Nejad, Seyed Alireza Salimi-Tabatabaee, Yekta Parsa, Soheila Yadollah-Damavandi, Tina Parsa, Amin Aidun
Publikováno v:
International Journal of Travel Medicine and Global Health, Vol 3, Iss 3, Pp 95-97 (2015)
Introduction: Overexpression of Human Epidermal Growth factor Receptor-2 (HER-2) is one of the most important prognostic and predictive factors of breast cancer, observed in 25% - 30% of breast carcinoma patients leading to poor prognosis and feasibl
Externí odkaz:
https://doaj.org/article/623cd70c7c1649d3b2c52adb50af10e8
Autor:
Soheila Yadollah-Damavandi, Amir Aidun, Seyed Abbas Mirmalek, Ehsan Shahverdi, Ehsan Jangholi, Tina Parsa, Fatemeh Elham Kani, Seyed Alireza Salimi-Tabatabaee, Yekta Parsa
Publikováno v:
Electronic Physician, Vol 8, Iss 5, Pp 2416-2424 (2016)
Electronic Physician
Electronic Physician
Background Histologically similar tumors may have different prognoses and responses to treatment. These differences are due to molecular differences. Hence, in this review, the biological interaction of breast cancer in several different areas is dis
Autor:
Amir Aidun, Tina Parsa, Soheila Yadollah-Damavandi, Yekta Parsa, Seyed Alireza Salimi-Tabatabaee, Mehdi Chavoshi-Nejad, Arianeb Mehrabi, Fatemeh Elham Kani, Seyed Abbas Mirmalek
Publikováno v:
International Journal of Travel Medicine and Global Health, Vol 3, Iss 3, Pp 95-97 (2015)
Introduction: Overexpression of Human Epidermal Growth factor Receptor-2 (HER-2) is one of the most important prognostic and predictive factors of breast cancer, observed in 25% - 30% of breast carcinoma patients leading to poor prognosis and feasibl